Literature DB >> 21558792

Stable serum miRNA profiles as potential tool for non-invasive lung cancer diagnosis.

Andreas Keller1, Petra Leidinger, Randi Gislefoss, Aage Haugen, Hilde Langseth, Peer Staehler, Hans-Peter Lenhof, Eckart Meese.   

Abstract

Circulating microRNAs in human serum have increasingly been recognized as stable markers for cancer detection. However, there is still a lack of miRNome wide studies over a long period of time with respect to pathogenic processes. We obtained serum samples from the janus serum bank collected prior and after diagnosis of lung cancer. We analyzed the abundance of 904 miRNAs in serum from eight cancer patients at three time points and from six healthy control individuals. Based on the identified miRNA signatures, hierarchical clustering and a self-organizing map identified three major clusters including one cluster containing most of the of the pre-diagnostic samples, a second cluster with mainly post-diagnostic samples, and a third cluster with mainly control samples. Correlation analyses showed that although the profiles were generally stable over several years, most obvious changes of the miRNA pattern seem to occur at a time close to diagnosis. Our findings support the idea that a developing lung cancer might be detectable years prior to diagnosis through a specific miRNA signature and that this signature changes during tumor development.
© 2011 Landes Bioscience

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21558792     DOI: 10.4161/rna.8.3.14994

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  54 in total

Review 1.  Circulating miRNAs as Diagnostic and Prognostic Biomarkers in Common Solid Tumors: Focus on Lung, Breast, Prostate Cancers, and Osteosarcoma.

Authors:  Michela Bottani; Giuseppe Banfi; Giovanni Lombardi
Journal:  J Clin Med       Date:  2019-10-11       Impact factor: 4.241

2.  Serum microRNA expression profile as a biomarker for the diagnosis of pertussis.

Authors:  Yiyue Ge; Kangchen Zhao; Yuhua Qi; Xiaoyan Min; Zhiyang Shi; Xian Qi; Yunfeng Shan; Lan Cui; Minghao Zhou; Yong Wang; Hua Wang; Lunbiao Cui
Journal:  Mol Biol Rep       Date:  2012-10-18       Impact factor: 2.316

3.  MicroRNAs As Biomarkers For Clinical Features Of Lung Cancer.

Authors:  Roland Hubaux; Daiana D Becker-Santos; Katey S S Enfield; Stephen Lam; Wan L Lam; Victor D Martinez
Journal:  Metabolomics (Los Angel)       Date:  2012-03-21

4.  Sources to variability in circulating human miRNA signatures.

Authors:  Andreas Keller; Trine Rounge; Christina Backes; Nicole Ludwig; Randi Gislefoss; Petra Leidinger; Hilde Langseth; Eckart Meese
Journal:  RNA Biol       Date:  2017-09-13       Impact factor: 4.652

5.  High-mobility group A1 proteins enhance the expression of the oncogenic miR-222 in lung cancer cells.

Authors:  Yunzhi Zhang; Teng Ma; Shuping Yang; Mingying Xia; Jing Xu; Haijia An; Yajun Yang; Shilin Li
Journal:  Mol Cell Biochem       Date:  2011-06-09       Impact factor: 3.396

6.  Applications of MicroRNAs in the Diagnosis and Prognosis of Lung Cancer.

Authors:  Jun Shen; Feng Jiang
Journal:  Expert Opin Med Diagn       Date:  2012-05

7.  Competitive learning suggests circulating miRNA profiles for cancers decades prior to diagnosis.

Authors:  Andreas Keller; Tobias Fehlmann; Christina Backes; Fabian Kern; Randi Gislefoss; Hilde Langseth; Trine B Rounge; Nicole Ludwig; Eckart Meese
Journal:  RNA Biol       Date:  2020-06-16       Impact factor: 4.652

8.  Methylation-associated silencing of MicroRNA-335 contributes tumor cell invasion and migration by interacting with RASA1 in gastric cancer.

Authors:  Zhengrong Li; Daojiang Li; Guoyang Zhang; Jianbo Xiong; Zhigang Jie; Heping Cheng; Yi Cao; Mengmeng Jiang; Liangqing Lin; Zhibiao Le; Shengxing Tan; Wenyu Zou; Binbin Gong; Shengrong Lin; Ke Yang
Journal:  Am J Cancer Res       Date:  2014-11-19       Impact factor: 6.166

Review 9.  The Role of Non-coding RNAs in Oncology.

Authors:  Frank J Slack; Arul M Chinnaiyan
Journal:  Cell       Date:  2019-11-14       Impact factor: 41.582

Review 10.  Clinical application of microRNA in gastric cancer in Eastern Asian area.

Authors:  Ming Gao; Hao Yin; Zhe-Wei Fei
Journal:  World J Gastroenterol       Date:  2013-04-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.